1. Home
  2. Analysis
  3. Lisinopril
  4. Retinal-pigmentation

Lisinopril and Retinal pigmentation - a phase IV clinical study of FDA data

Summary:

Retinal pigmentation is reported as a side effect among people who take Lisinopril (lisinopril), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Elmiron, and have Cystitis interstitial.

The phase IV clinical study analyzes which people have Retinal pigmentation when taking Lisinopril. It is created by eHealthMe based on reports of 343,814 people who have side effects when taking Lisinopril from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,656 Lisinopril users. Check the latest studies of Lisinopril.

What is Retinal pigmentation?

Retinal pigmentation (pigmentation of retina) is found to be associated with 106 drugs and 139 conditions by eHealthMe. Check the latest studies of Retinal pigmentation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

343,814 people reported to have side effects when taking Lisinopril.
Among them, 63 people (0.02%) have Retinal pigmentation.

Could Lisinopril cause Retinal pigmentation?

Among these 63 people:

How long have people been on Lisinopril when they have Retinal pigmentation? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 17.65 %
  • 2 - 5 years: 29.41 %
  • 5 - 10 years: 29.41 %
  • 10+ years: 23.53 %

What is the gender of people who have Retinal pigmentation when taking Lisinopril? *

  • female: 84.13 %
  • male: 15.87 %

What is the age of people who have Retinal pigmentation when taking Lisinopril? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.32 %
  • 40-49: 16.98 %
  • 50-59: 16.98 %
  • 60+: 54.72 %

What are other drugs people take besides Lisinopril? *

  1. Elmiron: 57 people, 90.48%
  2. Metformin: 16 people, 25.40%
  3. Amlodipine: 14 people, 22.22%
  4. Gabapentin: 11 people, 17.46%
  5. Omeprazole: 8 people, 12.70%
  6. Hydrocodone: 8 people, 12.70%
  7. Estradiol: 8 people, 12.70%
  8. Tamsulosin: 7 people, 11.11%
  9. Crestor: 6 people, 9.52%
  10. Vyvanse: 6 people, 9.52%

What are other side effects people have besides Retinal pigmentation? *

  1. Age-Related Macular Degeneration: 10 people, 15.87%
  2. Depression: 6 people, 9.52%
  3. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest): 6 people, 9.52%
  4. Vitreous Detachment (a condition of the eye in which the vitreous humour separates from the retina): 5 people, 7.94%
  5. Stress And Anxiety: 5 people, 7.94%
  6. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 4.76%
  7. Retinal Dystrophy (progressive weakness and wasting of the retina): 3 people, 4.76%
  8. Retinal Haemorrhage (bleeding from retina): 3 people, 4.76%
  9. Blindness: 2 people, 3.17%
  10. Drug Ineffective: 2 people, 3.17%

What are the existing conditions these people have? *

  1. Cystitis Interstitial (unknown cause characterized by bladder pain): 57 people, 90.48%
  2. Depression: 20 people, 31.75%
  3. High Blood Cholesterol: 19 people, 30.16%
  4. Multiple Allergies (allergy to multiple agents): 16 people, 25.40%
  5. Diabetes: 15 people, 23.81%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 20.63%
  7. Stress And Anxiety: 11 people, 17.46%
  8. Asthma: 11 people, 17.46%
  9. Pain: 9 people, 14.29%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 12.70%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and have Retinal pigmentation?

- Check whether Retinal pigmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lisinopril:

Retinal pigmentation treatments and more:

How severe was Retinal pigmentation and when was it recovered:

Expand to all the drugs that have ingredients of lisinopril:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal pigmentation:

Browse all the conditions that are associated with Retinal pigmentation:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on lisinopril (the active ingredients of Lisinopril) and Lisinopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.